#market trend
46 related articles.
Hereditary Cancer Germline Testing Across 21 European Countries: Why the Same Patient Can Receive a Different Diagnosis2026. 06. 21
ESHG 2026 Field Report: What Topped the Agenda2026. 06. 17
Why Secure Genomic Collaboration Matters2026. 06. 04
Resultados clave en el diagnóstico de enfermedades raras en México 20252026. 03. 19
Key Diagnostic Outcomes from Mexico in 20252026. 03. 19
The Rare Disease Diagnostics Market: Beyond “Expansion” Toward a True Paradigm Shift2026. 02. 24